Letter from the Editor 2020: Annual Summary and Introduction of the Thematic Issue and Guest Editor

References

• Ahn S, Siddiqi MH, Aceituno VC, Simu SY, Yang DC. 2016. Suppression of MAPKs/NF-κB activation induces intestinal anti-inflammatory action of ginsenoside Rf in HT-29 and RAW264.7 cells. Immunological Investigations. 45(5):439–49.
   PubMed Web of Science ®Google Scholar
• Al-Harbi NO, Imam F, Al-Harbi MM, Ansari MA, Zoheir KM, Korashy HM, Sayed-Ahmed MM, Attia SM, Shabanah OA, Ahmad SF. 2016. Dexamethasone attenuates LPS-induced acute lung injury through inhibition of NF-kappaB, COX-2, and pro-inflammatory mediators. Immunol Invest. 45(4):349–69.
   PubMed Web of Science ®Google Scholar
• Amsterdam D, Ostrov BE. 2018. The impact of the microbiome on immunosenescence. Immunol Invest. 47(8):801–11.
   PubMed Web of Science ®Google Scholar
• Asarat M, Apostolopoulos V, Vasiljevic T, Donkor O. 2016. Short-chain fatty acids regulate cytokines and Th17/Treg cells in human peripheral blood mononuclear cells in vitro. Immunol Invest. 45(3):205–22.
   PubMed Web of Science ®Google Scholar
• Azimi M, Aslani S, Mortezagholi S, Salek A, Javan MR, Rezaiemanesh A, Ghaedi M, Gholamzad M, Salehi E. 2016. Identification, isolation, and functional assay of regulatory T cells. Immunol Invest. 1–19. doi:10.1080/08820139.2016.1193869
   Web of Science ®Google Scholar
• Baric A, Brcic L, Gracan S, Skrabic V, Brekalo M, Simunac M, Lovric VT, Anic I, Barbalic M, Zemunik T, et al. 2019. Thyroglobulin antibodies are associated with symptom burden in patients with Hashimoto’s thyroiditis: a cross-sectional study. Immunol Invest. 48(2):198–209.
   PubMed Web of Science ®Google Scholar
• Crane JK. 2020. Metal nanoparticles in infection and immunity. Immunological Investigations.
   PubMed Web of Science ®Google Scholar
• Egilmez NK. 2020. Cytokine-encapsulated biodegradable microspheres for immune therapy. Immunological Investigations. 1–16. doi:10.1080/08820139.2020.1752713
   Web of Science ®Google Scholar
• Glassman FY, Dingman R, Yau HC, Balu-Iyer SV. 2020. Biological function and immunotherapy utilizing phosphatidylserine-based nanoparticles. Immunol Invest. 1–17. doi:10.1080/08820139.2020.1738456
   PubMed Web of Science ®Google Scholar
• Han BJ, Murphy JD, Qin S, Ye J, Uccello TP, Garrett-Larsen J, Belt BA, Prieto PA, Egilmez NK, Lord EM, et al. 2020. Microspheres encapsulating immunotherapy agents target the tumor-draining lymph node in pancreatic ductal adenocarcinoma. Immunological Investigations.
   Google Scholar
• Jafarinia M, Alsahebfosoul F, Salehi H, Eskandari N, Ganjalikhani-Hakemi M. 2020. Mesenchymal stem cell-derived extracellular vesicles: a novel cell-free therapy. Immunol Invest. 1–23. doi:10.1080/08820139.2020.1712416
   PubMed Web of Science ®Google Scholar
• Kirkwood KL. 2018. Inflammaging. Immunological Investigations. 47(8):770–73.
   PubMed Web of Science ®Google Scholar
• Kohnepoushi C, Nejati V, Delirezh N, Biparva P. 2019. Poly lactic-co-glycolic acid nanoparticles containing human gastric tumor lysates as antigen delivery vehicles for dendritic cell-based antitumor immunotherapy. Immunological Investigations. 1–15. doi:10.1080/08820139.2019.1610889
   Web of Science ®Google Scholar
• Lee G-J, Chu K-B, Inn K-S, Moon E-K, Quan F-S. 2019. Vaccine efficacy induced by 2009 pandemic H1N1 virus-like particles differs from that induced by split influenza virus. Immunol Inves. 1–13. doi:10.1080/08820139.2019.1694539
   PubMed Web of Science ®Google Scholar
• Liu XG, Hou M, Liu Y. 2017. TIGIT, a novel therapeutic target for tumor immunotherapy. Immunol Invest. 46(2):172–82.
   PubMed Web of Science ®Google Scholar
• Maccalli C, Parmiani G, Ferrone S. 2017. Immunomodulating and immunoresistance properties of cancer-initiating cells: implications for the clinical success of immunotherapy. Immunol Inves. 46(3):221–38.
   PubMed Web of Science ®Google Scholar
• Matic S, D’Souza DH, Tao W, Pangloli P, Dia VP. 2020. Bovine milk exosomes affect proliferation and protect macrophages against cisplatin-induced cytotoxicity. Immunol Inves. 1–15. doi:10.1080/08820139.2020.1769647
   PubMed Web of Science ®Google Scholar
• Mohammadnia-Afrouzi M, Hosseini AZ, Khalili A, Abediankenari S, Amari A, Aghili B, Nataj HH. 2016. Altered microRNA expression and immunosuppressive cytokine production by regulatory T cells of ulcerative colitis patients. Immunol Invest. 45(1):63–74.
   PubMed Web of Science ®Google Scholar
• Moon E-K, Kang H-J, Chu K-B, Lee S-H, Lee D-H, Soh Y, Quan F-S. 2019. Immune correlates of protection induced by virus-like particles containing 2009 H1N1 pandemic influenza HA, NA or M1 proteins. Immunol Inves. 48(4):355–66.
   PubMed Web of Science ®Google Scholar
• Morita K, Wang D, Baba R, Morimoto H, Song Y, Kanazawa T, Yoshida Y. 2019. Particulate matter, Asian sand dust delays cyclophosphamide-induced type 1 diabetes in NOD mice. Immunol Inves. 1–13. doi:10.1080/08820139.2019.1699569
   PubMed Web of Science ®Google Scholar
• Nader ND. 2017. Immunomodulation mechanisms in disease and in the surgical patient. Immunol Invest. 46(8):765–68.
   PubMed Web of Science ®Google Scholar
• Owen RS, Siddle HV. 2019. Devil facial tumours: towards a vaccine. Immunol Invest. 1–18. doi:10.1080/08820139.2019.1624770
   PubMed Web of Science ®Google Scholar
• Robert J. 2019. Introduction. Immunol Invest. 48(7):680–81.
   PubMed Web of Science ®Google Scholar
• Salmaninejad A, Zamani MR, Pourvahedi M, Golchehre Z, Hosseini Bereshneh A, Rezaei N. 2016. Cancer/testis antigens: expression, regulation, tumor invasion, and use in immunotherapy of cancers. Immunol Invest. 45(7):619–40.
   PubMed Web of Science ®Google Scholar
• Shahzad KA, Naeem M, Zhang L, Wan X, Song S, Pei W, Zhao C, Jin X, Shen C. 2019. Design and Optimization of PLGA Particles to Deliver Immunomodulatory Drugs for the Prevention of Skin Allograft Rejection. Immunological Investigations. 1–18. doi:10.1080/08820139.2019.1695134
   PubMed Web of Science ®Google Scholar
• Sharma RK, Cwiklinski K, Ravikumar Aalinkeel JL, Reynolds DE, Sykes EQ, James O, Mahajan SD, Schwartz SA. 2017. Immunomodulatory activities of curcumin-stabilized silver nanoparticles: efficacy as an antiretroviral therapeutic. Immunol Invest. 46(8):833–46.
   PubMed Web of Science ®Google Scholar
• Shenoy GN, Bhatta M, Loyall JL, Kelleher RJ Jr, Bernstein JM, Bankert RB. 2020. Exosomes represent an immune suppressive T cell checkpoint in human chronic inflammatory microenvironments. Immunol Invest. 1–18. doi:10.1080/08820139.2020.1748047
   PubMed Web of Science ®Google Scholar
• Shirkani A, Shahrooei M, Azizi G, Rokni-Zadeh H, Abolhassani H, Farrokhi S, Frans G, Bossuyt X, Aghamohammadi A. 2017. Novel mutation of ZAP-70-related combined immunodeficiency: first case from the national Iranian registry and review of the literature. Immunol Invest. 46(1):70–79.
   PubMed Web of Science ®Google Scholar
• Shu S, Matsuzaki J, Want MY, Conway A, Benjamin-Davalos S, Allen CL, Koroleva M, Battaglia S, Odunsi A, Minderman H, et al. 2020. An immunosuppressive effect of melanoma-derived exosomes on NY-ESO-1 antigen-specific human CD8+ T cells is dependent on IL-10 and independent of BRAFV600E mutation in melanoma cell lines. Immunological Investigations.
   Google Scholar
• Wang D, Jingcai L, Jinfei Y, Hou H, Leenhouts K, Van Roosmalen ML, Tiejun G, Jiang C, Kong W, Yongge W. 2018. A novel PspA protein vaccine intranasal delivered by bacterium-like particles provides broad protection against pneumococcal pneumonia in mice. Immunol Invest. 47(4):403–15.
   PubMed Web of Science ®Google Scholar
• Wang T, Shi W, Fan T, Wan X, Chen YH, Ruan Q. 2016. c-rel is required for the induction of pTregs in the eye but not in the gut mucosa. Immunol Invest. 1–11. doi:10.3109/08820139.2016.1172639
   Web of Science ®Google Scholar
• Zhang M, Yang J, Zhou J, Gao W, Zhang Y, Lin Y, Wang H, Ruan Z, Bing N. 2019. Prognostic values of CD38+CD101+PD1+CD8+ T cells in pancreatic cancer. Immunol Invest. 48(5):466–79.
   PubMed Web of Science ®Google Scholar
• Zhu B, He T, Gao X, Shi M, Sun H. 2019. Evaluation and characteristics of immunological adjuvant activity of purified fraction of Albizia julibrissin saponins. Immunol Invest. 48(3):283–302.
   PubMed Web of Science ®Google Scholar